How Racism Is Shaping the Coronavirus Pandemic
By Isaac Chotiner,
The New Yorker
| 05. 07. 2020
The historian Evelynn Hammonds talks about how false theories of “innate difference and deficit in black bodies” have shaped American responses to disease, from yellow fever to syphilis to COVID-19.
Evelynn Hammonds, who chairs Harvard’s department of the history of science, has spent her career studying the intersection of race and disease. She wrote a history of New York City’s attempt, a century ago, to control diphtheria, and is currently at work on a book of essays on the history of race, from Jefferson to genomics. Hammonds’s area of expertise is especially relevant today: while the data is incomplete, at this point in time, African-Americans represent nearly a third of U.S. deaths from the coronavirus pandemic and thirty per cent of covid-19 cases, despite making up only about thirteen per cent of the population. Hammonds noted recently, “This new development of what has happened with the pandemic with respect to African-American communities” is “perhaps an old development.”
I spoke by phone with Hammonds, who is currently hosting a series of Webinars with academics and experts at Harvard on African-Americans and epidemics in American history, from the eighteenth century to the present day. As she stated in one of the sessions, “I can’t imagine saying that we have to...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...